In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OccuRx Pty. Ltd.

Latest From OccuRx Pty. Ltd.

Venture Funding Deals, June 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced April through May 2015.

BioPharmaceutical Medical Device

Out Of The Blocks, May 2015

Brief profiles of these recently formed companies: Admera Health, Denali Therapeutics, Esperas Pharma, and OccuRx.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Inflammation
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • OccuRx Pty. Ltd.
  • Senior Management
  • Darren Kelly, PhD, CEO & Mng. Dir.
    Marc Gleeson, R&D, Bus. Dev. Consultant
  • Contact Info
  • OccuRx Pty. Ltd.
    Phone: 3 9657 0704
    Level 9, 278 Collins St.
    Melbourne, 3000